Work

A Phase II Multicenter Study of the Histone Deacetylase Inhibitor (HDACi) Abexinostat (PCI-24781) in Relapsed/Refractory Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.55.55

Authors: Andrew M. Evens, Julie M Vose, Wael Harb, Leo I. Gordon, Robert Langdon, Barbara Grant, Julian Sprague, Clara Plasencia, Mint Sirisawad, Jeanne Yue, Ying Luan, Aaron Siek, Lei Zhou, Sriram Balasubramanian, Nancy L. Bartlett

Institutions: University of Massachusetts Chan Medical School, Nebraska Medical Center, Horizon Oncology Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Vermont, Pharmacyclics (United States), Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556993272

FWCI: 3.541

Cites:

Cited by: 25

Related to: 10